Background Serum albumin and prealbumin are both negative acute-phase reactants, and usually at low levels in stress. We aim to determine their predictive values for poor outcome of traumatic brain injury (TBI). Methods A total of 326 patients of TBI were enrolled and followed-up by telephone 6 months after discharge. They were divided into a favorable group (GOS: 3 to 5) and an unfavorable group (GOS: 1 to 2). Serum albumin and prealbumin were measured from vein blood within 24 h after admission. Results Ninety one (27.9%) patients were with poor outcome (GOS: 1 to 2). The unfavorable group had lower albumin and prealbumin (P<0.001). Albumin and prealbumin were both positively correlated with GCS (r = 0.489, P<0.001; r = 0.222, P<0.001, respectively) and GOS (r = 0.518, P<0.001; r = 0.314, P<0.001, respectively). After adjustment for confounding factors, the odds ratios of albumin and prealbumin were 0.866, 95% CI: 0.829 to 0.904 and 0.990, 95% CI: 0.985 to 0.995, respectively. In subgroup of GCS≤8 (n = 101), the crude and adjusted odds ratios of serum albumin were both statistically significant (P = 0.027, P = 0.033, respectively), while prealbumin were not (P = 0.553, P = 0.576, respectively). The AUC of albumin for predicting poor outcome was 0.762, 95% CI: 0.712 to 0.807, which was significantly higher than that of prealbumin (0.664, 95% CI: 0.610 to 0.715). In analyses of all patients and subgroup of GCS≤8, the AUCs of serum albumin were both significantly higher than those of prealbumin (P = 0.001, P = 0.045, respectively). Conclusions Both serum albumin and prealbumin could predict the poor outcome of TBI, but the former is much better, especially, in patients with severe TBI.
References
[1]
Rosenfeld JV, Maas AI, Bragge P, Morganti-Kossmann MC, Manley GT, et al. (2012) Early management of severe traumatic brain injury. Lancet 380: 1088–1098. doi: 10.1016/s0140-6736(12)60864-2
[2]
Czeiter E, Mondello S, Kovacs N, Sandor J, Gabrielli A, et al. (2012) Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J Neurotrauma 29: 1770–1778. doi: 10.1089/neu.2011.2127
[3]
Lingsma HF, Roozenbeek B, Steyerberg EW, Murray GD, Maas AI (2010) Early prognosis in traumatic brain injury: from prophecies to predictions. Lancet Neurol 9: 543–554. doi: 10.1016/s1474-4422(10)70065-x
[4]
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837–845. doi: 10.2307/2531595
[5]
Collins N (2001) The difference between albumin and prealbumin. Adv Skin Wound Care 14: 235–236. doi: 10.1097/00129334-200109000-00009
[6]
Cabassi A, Champlain JD, Maggiore U, Parenti E, Coghi P, et al.. (2013) Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: Results from a pilot study in elderly chronic heart failure patients. Int J Cardiol.
[7]
Kawai H, Ota H (2012) Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg 36: 2853–2857. doi: 10.1007/s00268-012-1766-y
[8]
Gao C, Zhang B, Zhang W, Pu S, Yin J, et al. (2011) Serum prealbumin (transthyretin) predict good outcome in young patients with cerebral infarction. Clin Exp Med 11: 49–54. doi: 10.1007/s10238-010-0103-8
[9]
Rocca B, Bidet PF, Courtinat C, Lecoq SH, Chevalier A, et al. (1987) [Lack of prognostic value of the determination of 3 serum proteins during the acute phase of brain injury]. Ann Fr Anesth Reanim 6: 476–481.
Rossi JL, Ralay RH, Patel F, Chrzaszcz M, Venkatesan C, et al. (2011) Albumin causes increased myosin light chain kinase expression in astrocytes via p38 mitogen-activated protein kinase. J Neurosci Res 89: 852–861. doi: 10.1002/jnr.22600
[12]
Bernard F, Al-Tamimi YZ, Chatfield D, Lynch AG, Matta BF, et al. (2008) Serum albumin level as a predictor of outcome in traumatic brain injury: potential for treatment. J Trauma 64: 872–875. doi: 10.1097/ta.0b013e31803428cc
[13]
Nelson DW, Rudehill A, MacCallum RM, Holst A, Wanecek M, et al. (2012) Multivariate outcome prediction in traumatic brain injury with focus on laboratory values. J Neurotrauma 29: 2613–2624. doi: 10.1089/neu.2012.2468
[14]
Smith RL, Lin JC, Adelson PD, Kochanek PM, Fink EL, et al. (2012) Relationship between hyperglycemia and outcome in children with severe traumatic brain injury. Pediatr Crit Care Med 13: 85–91. doi: 10.1097/pcc.0b013e3182192c30
[15]
Seyed SS, Bidabadi E, Seyed SS, Mashouf M, Salamat F, et al. (2012) Association of persistent hyperglycemia with outcome of severe traumatic brain injury in pediatric population. Childs Nerv Syst 28: 1773–1777. doi: 10.1007/s00381-012-1753-5
[16]
Matsushima K, Peng M, Velasco C, Schaefer E, Diaz-Arrastia R, et al. (2012) Glucose variability negatively impacts long-term functional outcome in patients with traumatic brain injury. J Crit Care 27: 125–131. doi: 10.1016/j.jcrc.2011.08.012
[17]
Melo JR, Di Rocco F, Blanot S, Laurent-Vannier A, Reis RC, et al. (2010) Acute hyperglycemia is a reliable outcome predictor in children with severe traumatic brain injury. Acta Neurochir (Wien) 152: 1559–1565. doi: 10.1007/s00701-010-0680-z
[18]
Jiang JY, Gao GY, Li WP, Yu MK, Zhu C (2002) Early indicators of prognosis in 846 cases of severe traumatic brain injury. J Neurotrauma 19: 869–874. doi: 10.1089/08977150260190456
[19]
Rovlias A, Kotsou S (2000) The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46: : 335–342, 342–343.
[20]
Kramer AH, Roberts DJ, Zygun DA (2012) Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care 16: R203. doi: 10.1186/cc11812
[21]
Vespa P, McArthur DL, Stein N, Huang SC, Shao W, et al. (2012) Tight glycemic control increases metabolic distress in traumatic brain injury: a randomized controlled within-subjects trial. Crit Care Med 40: 1923–1929. doi: 10.1097/ccm.0b013e31824e0fcc
[22]
Shutter L (2012) Glucose control in traumatic brain injury: extra sweetness required. Crit Care Med 40: 1995–1996. doi: 10.1097/ccm.0b013e3182514c15
[23]
Sharma D, Vavilala MS (2012) Perioperative management of adult traumatic brain injury. Anesthesiol Clin 30: 333–346. doi: 10.1016/j.anclin.2012.04.003
[24]
Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, et al. (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357: 874–884. doi: 10.1056/nejmoa067514
[25]
Cooper DJ, Myburgh J, Heritier S, Finfer S, Bellomo R, et al. (2013) Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma 30: 512–518. doi: 10.1089/neu.2012.2573
[26]
Yang TJ, Fei MM, Ye W, Pan AJ, Liu B (2013) [Effect of albumin and hemoglobin level on prognosis of patients with uncomplicated severe traumatic brain injury: a retrospective cohort study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 25: 301–305.
[27]
Rodling WM, Olivecrona M, Nystrom F, Koskinen LO, Naredi S (2009) Fluid therapy and the use of albumin in the treatment of severe traumatic brain injury. Acta Anaesthesiol Scand 53: 18–25. doi: 10.1111/j.1399-6576.2008.01798.x
[28]
Belayev L, Alonso OF, Huh PW, Zhao W, Busto R, et al. (1999) Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats. J Neurotrauma 16: 445–453. doi: 10.1089/neu.1999.16.445
